Stay updated on CD40-L Blockade in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the CD40-L Blockade in GVHD Prevention Clinical Trial page.

Latest updates to the CD40-L Blockade in GVHD Prevention Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows Revision: v3.3.3 and removes references to HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision history now shows the addition of 'Revision: v3.3.2' and the removal of 'Revision: v3.2.0'.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded a References section to the study record history. Removed the generic government funding/operating status notice.SummaryDifference0.6%

- Check69 days agoChange DetectedThe new screenshot shows the same page layout and content as the previous screenshot, with no visible changes to core trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check98 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

- Check105 days agoChange DetectedThe page metadata has been updated to v3.1.0 with a current date and new study status, replacing the older revision v3.0.2 and 2025-06-05 date.SummaryDifference1%

Stay in the know with updates to CD40-L Blockade in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD40-L Blockade in GVHD Prevention Clinical Trial page.